CN100427454C - Method for producing difluoro-acetyl-acetic acid alkylesters - Google Patents

Method for producing difluoro-acetyl-acetic acid alkylesters Download PDF

Info

Publication number
CN100427454C
CN100427454C CNB2004800185125A CN200480018512A CN100427454C CN 100427454 C CN100427454 C CN 100427454C CN B2004800185125 A CNB2004800185125 A CN B2004800185125A CN 200480018512 A CN200480018512 A CN 200480018512A CN 100427454 C CN100427454 C CN 100427454C
Authority
CN
China
Prior art keywords
alkyl
structural formula
difluoro
acid
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CNB2004800185125A
Other languages
Chinese (zh)
Other versions
CN1812959A (en
Inventor
B·加伦卡姆普
L·缪德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Publication of CN1812959A publication Critical patent/CN1812959A/en
Application granted granted Critical
Publication of CN100427454C publication Critical patent/CN100427454C/en
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/113Esters of phosphoric acids with unsaturated acyclic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/313Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a method for producing 4,4-difluoro-acetyl-acetic acid alkylesters using three steps, thereinto, in the first step, the 4-chlorin-4,4-difluoro-acetyl-acetic acid alkylesters reacts with trialkyl phosphites of structure formula (III), P(OR<1>)3 (III), thereinto, R<1> represents C1-C4 alkyl, residues R<1> is same or different through fair and foul, so as to prepare structure formula (IV) alkylphosphonate. The structure formula (IV) compound reacts with the structure formula (V) amic, thereinto, R<2> and R<3> represent hydrogen or C1-C4 alkyl respectively, or -CH2-CH2-O-CH2-CH2-, so as to prepare structure formula (VI) enamine, thereinto, R<2> and R<3> have the meaning as above mentioned, the compound of structure formula (VI) hydrolyzes in the third steps under the state of acid existing.

Description

The method for preparing difluoro-acetyl-acetic acid alkylesters
The present invention relates to a kind of by 4-chloro-4,4-difluoro-acetyl-acetic acid alkylesters preparation 4, the novel method of 4-difluoro-acetyl-acetic acid alkylesters (4,4-two fluoro-3-ketobutyric acid alkyl esters), and 4-chloro-4, the 4-difluoro-acetyl-acetic acid alkylesters is made by 2-chlorine difluoroacetic acid alkyl ester again.
Known 4, the reaction acquisition that 4-difluoro methyl aceto acetate can be by ethyl difluoro in the presence of sodium hydride and ethyl acetate is (with reference to Tetrahedron 2001,57,2689-2700).But the productive rate that is somebody's turn to do reaction 25% is also unsatisfactory.In addition, the by product methyl aceto acetate that obtains also is difficult to separate from desired product.
Equally, known 4, the reaction acquisition that 4-difluoro methyl aceto acetate can be by ethyl difluoro in the presence of zinc and ethyl bromoacetate is (with reference to Tetrahedron 1996,52,119-130).But the productive rate that should react and desirable also far apart.
And a common defective of above-mentioned two kinds of methods is that used ethyl difluoro price is very expensive, and is therefore not attractive for large-scale industrial production as educt (educt).
Also known chloro difluoro ethanoyl as the aromatic hydrocarbons substituting group can with sodium formaldehyde sulphoxylate dihydrate reduction (with reference to Tetrahedron Lett.2001,42,4811-4814).But this reaction can't change into 4-chloro-4,4-difluoro methyl aceto acetate.
Therefore, task of the present invention provides and a kind ofly can obtain high purity 4, the novel method of the economy of 4-difluoro-acetyl-acetic acid alkylesters with high overall yield.
Therefore, theme of the present invention is 4 of a kind of preparation structural formula (I), the method for 4-difluoro-acetyl-acetic acid alkylesters,
Figure C20048001851200051
Wherein R represents alkyl,
It is characterized in that
A) exist The first stepIn, the 4-chloro-4 of structural formula (II), the trialkyl phosphite reaction of 4-difluoro-acetyl-acetic acid alkylesters and structural formula (III),
Figure C20048001851200052
Wherein R has aforesaid implication
P(OR 1) 3 (III)
R wherein 1Represent C 1-C 4Alkyl, and residue R 1Under any circumstance can be identical or different, the alkyl phosphonates of the structural formula that is obtained (IV) thus
Figure C20048001851200061
Wherein R and R 1Has aforesaid implication
Second stepIn randomly in the presence of thinner with the reaction of the amine of structure formula V,
Wherein
R 2And R 3Represent hydrogen or C independently of one another 1-C 8Alkyl or common representative-CH 2-CH 2-O-CH 2-CH 2-,-CH 2-CH 2-S-CH 2-CH 2-or-CH 2-CH 2-N (R 4)-CH 2-CH 2-,
R 4Represent hydrogen or C 1-C 8Alkyl,
The enamine of the structural formula that is obtained (VI) thus
Figure C20048001851200063
Wherein R, R 2And R 3Has aforesaid implication
The 3rd stepIn hydrolysis in the presence of acid.
Beat all is that the alkyl phosphonates of structural formula (IV) can not be converted into desirable final product by acid hydrolysis, but observes decomposition under the described conditions.Same beat allly be, in second step of the inventive method, desirable 4,4-difluoro-acetyl-acetic acid alkylesters and corresponding phosphonic amide can not obtain from the alkyl phosphonates of structural formula (IV) and the amine of structure formula V, but obtain the enamine and the phosphodiester ammonium salt of structural formula (VI).By acid hydrolysis, described enamine unexpectedly is easy to be converted into 4 of structural formula (I), 4-difluoro acetylacetic ester.For this reason, the separation of described enamine is unnecessary.
Therefore method of the present invention has overcome above-mentioned known preparation method's defective, has obtained high purity 4 with high yield, the 4-difluoro-acetyl-acetic acid alkylesters.In addition, the present invention be advantageous in that the ester class of the etheric acid that may exist with the impurity form in the 4-chloro-4-difluoro-acetyl-acetic acid alkylesters of structural formula (II) is easy to remove from reaction mixture.In the conversion process, the ester class of etheric acid not with the reaction of the trialkyl phosphite of structural formula (III), and can from the alkyl phosphonates of structural formula (IV), remove by distilling.
From 4-chloro-4,4-difluoro methyl aceto acetate, tricresyl phosphite methyl ester and di-isopropyl are amine-initiated, and method of the present invention can be expressed as following reaction scheme figure.
Figure C20048001851200071
Can by method of the present invention obtain 4, the keto-acid that the 4-difluoro-acetyl-acetic acid alkylesters both can structural formula (I) also can enol form exist:
Figure C20048001851200072
Keto-acid enol form
Remove 4, outside the 4-difluoro-acetyl-acetic acid alkylesters, also can obtain the hydrate of this compounds by method of the present invention:
Figure C20048001851200073
Hydrate
Therefore, remove 4, outside the 4-difluoro-acetyl-acetic acid alkylesters (keto-acid and enol form), corresponding hydrate also is appreciated that the product of the inventive method.According to the difference of follow-up chemical treatment method, whole three kinds of forms of product, or some only independent form can further be reacted (with reference to hereinafter).
Be used as the 4-chloro-4 of the structural formula (II) of starting raw material in the first step of the present invention (a), the 4-difluoro-acetyl-acetic acid alkylesters is that known compound is (with reference to Journal of FluorineChemistry 1992, 56, 271-284; The chemistry journal 1983, 41, 729-729 and chemical abstracts 1984, 100, digest numbers 22308; EP-A 0 082 252).Described compound can be according to for example following method preparation
B) the chloro difluoroacetic acid alkyl ester of structural formula (VII) in the presence of alkali and thinner with the reaction of the alkyl acetate of structural formula (VIII),
Figure C20048001851200081
Wherein R has aforesaid implication
Figure C20048001851200082
Wherein R has aforesaid implication.
The enamine of the alkyl phosphonates of structural formula (IV) and structural formula (VI) is new compound.Described compound can prepare according to method of the present invention (a).
The chloro difluoroacetic acid alkyl ester of the trialkyl phosphite of structural formula (III), the amine of structure formula V, structural formula (VII) (feasible preparation method sees preparation embodiment) and the alkyl acetate of structural formula (VIII) are known synthesis of chemicals.
In the inventive method (a) The first stepThe 4-chloro-4 of middle utilization structure formula (II), the 4-difluoro-acetyl-acetic acid alkylesters, wherein R preferably represents C 1-C 8Alkyl, C 1-C 6Alkyl, Methyl, ethyl, n-propyl, sec.-propyl, normal-butyl, isobutyl-, sec-butyl, the tertiary butyl,
Figure C20048001851200085
Methyl or ethyl.
In the inventive method (a) The first stepThe trialkyl phosphite of middle utilization structure formula (III), wherein R 1Under any circumstance can be identical or different.R 1Preferred represent methylidene, ethyl, n-propyl, sec.-propyl, normal-butyl, isobutyl-, sec-butyl, the tertiary butyl,
Figure C20048001851200087
Methyl or ethyl.
Preferred alkyl phosphonates is the described compound of structural formula (IV), and wherein R has above respectively as preferably, more preferably, most preferably reaching the most preferred given implication, and R wherein 1Under any circumstance can be identical or different, and have above respectively as preferred or more preferably given implication.
In the inventive method (a) Second stepThe amine of middle utilization structure formula V, wherein R 2And R 3Preferably represent hydrogen, C independently of one another 1-C 6Alkyl or common representative-CH 2-CH 2-O-CH 2-CH 2-,-CH 2-CH 2-S-CH 2-CH 2-or-CH 2-CH 2-N (R 4)-CH 2-CH 2-,
Figure C20048001851200091
Hydrogen, methyl, ethyl, n-propyl, sec.-propyl, normal-butyl, isobutyl-, sec-butyl, the tertiary butyl or common representative-CH 2-CH 2-O-CH 2-CH 2-,
Figure C20048001851200092
Represent sec.-propyl, isobutyl-, sec-butyl, the tertiary butyl or common representative-CH independently of one another 2-CH 2-O-CH 2-CH 2-, Under any circumstance represent sec.-propyl.R in the structure formula V 4Preferred hydrogen or the C of representing 1-C 6Alkyl,
Figure C20048001851200094
Hydrogen, methyl, ethyl, n-propyl, sec.-propyl, normal-butyl, isobutyl-, sec-butyl or the tertiary butyl.
Preferred enamine is the described compound of structural formula (VI), and wherein R has above respectively as preferably, more preferably, most preferably reaching the most preferred given implication, R 2And R 3Have above respectively as preferably, more preferably reaching most preferably given implication.
The first step of the inventive method (a)
The inventive method (a) The first stepUsually under the condition of not having other thinner, implement.Yet this step reaction also can be used thinner (for example methylene dichloride) in addition.
The inventive method (a) The first stepCan in wide relatively temperature range, implement.Typical temperature is 10 ℃ to 50 ℃, preferred 20 ℃ to 40 ℃, and more preferably 20 ℃ to 30 ℃.Most preferably The One stepIn being reflected at 25 ℃ to 30 ℃ and causing down of each reactive component.Further be reflected at 40 ℃ to 45 ℃ and carry out, be chilled to room temperature then.
Reaction times is not crucial, can how much selecting in the scope of broad according to production lot.Generally speaking, each reactant combines and reaches 150 minutes most, and preferably the longest is 120 minutes, and more preferably the longest is 90 minutes.Further the time of reaction is generally 3 hours and cool overnight (promptly about 16 hours).
Handle and carry out according to a conventional method.In the inventive method (a) The first stepIn, at first, carry out reduction vaporization, and pass through the product in this step of fractionation by distillation.
Implementing the inventive method (a) The first stepIn the process, for the 4-chloro-4 of the structural formula (II) of 1mol, 4-difluoro-acetyl-acetic acid alkylesters, the trialkyl phosphite of employed structural formula (III) is generally 0.5mol to 5mol, preferred 0.5mol to 3mol, more preferably 1mol to 2mol, most preferably 1.2mol to 1.7mol.
Second step of the inventive method (a)
The inventive method (a) Second stepRandomly in the presence of thinner, implement.All be fit to for all conventional organic solvents of inert for this step reaction.What preferably use is optional halogenated aliphatic hydrocrbon, alicyclic hydrocarbon or aromatic hydrocarbon, for example sherwood oil, hexane, heptane, hexanaphthene, methylcyclohexane, benzene,toluene,xylene, naphthalane, chlorobenzene, dichlorobenzene or methylene dichloride; Ether, for example ether, isopropyl ether, methyl tertiary butyl ether, tert amyl methyl ether(TAME), diox, tetrahydrofuran (THF), 1,2-glycol dimethyl ether, 1,2-diethoxyethane or methyl-phenoxide; Nitrile, for example acetonitrile, propionitrile, n-Butyronitrile, isopropyl cyanide or benzonitrile; Acid amides, N for example, dinethylformamide, N,N-dimethylacetamide, N-methyl formyl aniline, N-Methyl pyrrolidone or hexamethylphosphoramide; Sulfoxide, for example dimethyl sulfoxide (DMSO); Or sulfone, for example tetramethylene sulfone.
The inventive method (a) Second stepCan in wideer temperature range, implement.The general temperature that adopts 10 ℃ to 100 ℃, preferably each reactive component is 20 ℃ to 30 ℃ mixing, then 30 ℃ to 100 ℃, preferred 50 ℃ to 75 ℃ reactions.
Reaction times is not crucial, can how much selecting in the scope of broad according to production lot.Generally speaking, reactant mixed in several minutes to 60 minutes, preferred 10 to 30 minutes, made its reaction several hours then, and preferably the longest is 24 hours, and more preferably the longest is 20 hours.
Handle and carry out according to a conventional method. Second stepIn reaction mixture is chilled to room temperature, with sodium chloride solution and water washing, with thick product drying and reduction vaporization.Separate with other impurity by the enamine of distillation then structural formula (VI).
Implementing the inventive method (a) Second stepIn the process, for the alkyl phosphonates of the structural formula (IV) of 1mol, the amine of employed structure formula V is generally 2.5mol to 5mol, preferred 3mol to 5mol, more preferably 2mol to 4mol.
The 3rd step of the inventive method (a)
The inventive method (a) The 3rd stepIn hydrolysis in the presence of acid, implement preferred randomly sulfuric acid, phosphoric acid or the hydrochloric acid of dilute with water, more preferably hydrochloric acid, the most preferably mixture of hydrochloric acid and water.
The inventive method (a) The 3rd stepCan in wideer temperature range, implement.Generally speaking, adopt 10 ℃ to 50 ℃ temperature, preferred 20 ℃ to 30 ℃.
Reaction times is not crucial, can be according to the scope of how much selecting broad of production lot.Generally speaking, each reactant mixed number minute is to the longest 60 minutes, preferred 10 to 30 minutes, and makes its reaction several hours, and preferably the longest is 24 hours, and more preferably the longest is 20 hours.
Handle and carry out according to a conventional method. The 3rd stepMiddle reaction mixture washs with sodium chloride solution and sodium hydrogen carbonate solution, with thick product drying and reduction vaporization usually with the solvent extraction that is fit to.By distilling 4 of structural formula (I), the 4-difluoro-acetyl-acetic acid alkylesters separates with other impurity then.
Implementing the inventive method (a) The 3rd stepIn the process, for the enamine of the structural formula (VI) of 1mol, employed acid is generally 0.5mol to 5mol, preferred 1mol to 5mol, more preferably 1mol to 2.5mol.
Method of the present invention (b)
In method of the present invention (b), the alkyl acetate of the chloro difluoroacetic acid alkyl ester of utilization structure formula (VII) and structural formula (VIII), wherein R preferably represents C 1-C 8Alkyl,
Figure C20048001851200111
C 1-C 6Alkyl,
Figure C20048001851200112
Methyl, ethyl, n-propyl, sec.-propyl, normal-butyl, isobutyl-, sec-butyl, the tertiary butyl,
Figure C20048001851200113
Methyl or ethyl.
Method of the present invention (b) is implemented in the presence of the alkali that is fit to.All conventional mineral alkali and organic basess all are fit to.Described alkali preferably includes alkaline-earth metal and alkali-metal hydride, amide, alcoholate, for example sodium hydride, sodium amide, lithium diisopropylamine (LDA), sodium methylate, sodium ethylate, potassium tert.-butoxide, more preferably lithium diisopropylamine (LDA) and sodium hydride.
Method of the present invention (b) is implemented in the presence of thinner.All be fit to for all conventional organic solvents of inert for this step reaction.What preferably use is optional halogenated aliphatic hydrocrbon, alicyclic hydrocarbon or aromatic hydrocarbon, for example sherwood oil, hexane, heptane, hexanaphthene, methylcyclohexane, benzene,toluene,xylene, naphthalane, chlorobenzene, dichlorobenzene or methylene dichloride; Ether, for example ether, isopropyl ether, methyl tertiary butyl ether, tert amyl methyl ether(TAME), diox, tetrahydrofuran (THF), 1,2-glycol dimethyl ether, 1,2-diethoxyethane or methyl-phenoxide; Nitrile, for example acetonitrile, propionitrile, n-Butyronitrile, isopropyl cyanide or benzonitrile; Acid amides, N for example, dinethylformamide, N,N-dimethylacetamide, N-methyl formyl aniline, N-Methyl pyrrolidone or hexamethylphosphoramide; Sulfoxide, for example dimethyl sulfoxide (DMSO); Or sulfone, for example tetramethylene sulfone.
Method of the present invention (b) can be implemented in wide temperature range.Generally speaking, adopt-80 ℃ to+100 ℃ temperature, preferred-70 ℃ to 0 ℃.
Reaction times is not crucial, can be according to the scope of how much selecting broad of production lot.Generally speaking, each reactant mixed number minute is to the longest 180 minutes, preferred 10 to 90 minutes, and makes its reaction several hours, and preferably the longest is 24 hours, and more preferably the longest is 16 hours.
Handle and carry out according to a conventional method.Usually with the reaction mixture neutralization, be separated, with the sodium chloride solution washing, with thick product drying and reduction vaporization.By the 4-chloro-4 of distillation with structural formula (II), the 4-difluoro-acetyl-acetic acid alkylesters separates with other impurity then.
In the process of implementing the inventive method (b), for the chloro difluoroacetic acid alkyl ester of the structural formula (VII) of 1mol, the alkyl acetate of employed structural formula (VIII) is generally 0.5mol to 5mol, preferred 1mol to 5mol, more preferably 1mol to 2.5mol.
The inventive method (a) and institute (b) implement under normal pressure in steps usually.But under also can or reducing pressure at high pressure-and being generally 0.1 to 50bar, a certain step that preferred 1bar to 10bar-enforcement is independent or institute are in steps.
Can be by 4 of method of the present invention (a) acquisition, the 4-difluoro-acetyl-acetic acid alkylesters is valuable intermediate for pyrazolyl carboxylic acid for preparing the difluoromethyl replacement and thiazolyl carboxylic acid derivative, and described derivative is the precursor (reference example such as WO 02/08197 and DE-A 102 15 292) with compound of anti-mycotic activity.
For example, 4, the 4-difluoro-acetyl-acetic acid alkylesters can be earlier and diacetyl oxide and alkyl orthoformate be converted into 2-(difluoro ethanoyl)-3-alkoxy propone acid alkyl ester (productive rate of ethyl ester is higher than 90%, with reference to preparation embodiment) with higher productive rate.Obtain 1-methyl-3-difluoromethyl-pyrazoles-4-carboxylic acid (productive rate is higher than 65% with regard to ethyl ester) with the methylhydrazine cyclisation.Unwanted isomer (1-methyl-5-difluoromethyl-pyrazoles-4-carboxylic acid) can pass through Crystallization Separation.Conversion process can be expressed as following reaction scheme figure:
Figure C20048001851200121
Equally, 4, the 4-difluoro-acetyl-acetic acid alkylesters also can first chlorination, obtain monochloroization and dichloride product (2 this moment, 2-two chloro-4,4-two fluoro-3-ketobutyric acid alkyl ester and 2-chloro-4,4-two fluoro-3-ketobutyric acid alkyl esters), the two all can almost make 3-methyl-4-difluoromethyl thiazole-5-carboxylic acid alkyl ester (with reference to following route map) with the thioacetamide reaction quantitatively:
Figure C20048001851200122
The further example of following examples is explained above explanation, wherein discuss of the present invention 4, the preparation method of 4-difluoro-acetyl-acetic acid alkylesters and be used to prepare the purposes of difluoromethyl substituted heterocycle.Yet described embodiment should not explain in the mode of restriction.
Preparation embodiment
Embodiment 1:
Step 1:
3-[(dimethoxy phosphoryl) oxygen base]-4, the system of 4-difluoro fourth-3-olefin(e) acid ethyl ester (IV-1) Be equipped with
Figure C20048001851200131
Under the condition of ice bath cooling and gas generation, in the time of 25 ℃ to 30 ℃ with the tricresyl phosphite methyl ester (232.0g 1.87mol) splashed into 4-chloro-4 in 90 minutes, 4-difluoro methyl aceto acetate (305.1g, content 77.0%, 1.17mol) in.30 ℃ are continued down to stir 1 hour, stirred 3 hours down at 40 ℃ to 45 ℃ then.During processing reaction mixture is chilled to room temperature (about 16 hours) and reduction vaporization.Thick product is further purified by distillation.
Obtain 302.0g (97%, theoretical value 91%) 3-[(dimethoxy phosphoryl) the oxygen base]-4,4-difluoro fourth-3-olefin(e) acid ethyl ester (92-95 ℃ of 0.4hPa boiling point).
Step 2:
3-(diisopropylaminoethyl)-4, the preparation of 4-difluoro fourth-3-olefin(e) acid ethyl ester (VI-1)
Figure C20048001851200132
With diisopropylamine (15.2g 0.15mol) splashes into 3-[(dimethoxy phosphoryl) oxygen base]-4,4-difluoro fourth-3-olefin(e) acid ethyl ester (IV-1) (14.2g, 97%, 0.05mol) be dissolved in the solution of 100ml methyl tertiary butyl ether 10 minutes dropping time.Reflux was chilled to room temperature with reaction mixture after 19 hours, and the sodium chloride solution washed twice with 10%, each 10ml are with dried over sodium sulfate, filtration and reduction vaporization.Resistates is distilled to treat further use.
Obtain 8.8g (95%, theoretical value 67.4%) 3-(diisopropylaminoethyl)-4,4-difluoro fourth-3-olefin(e) acid ethyl ester (55-57 ℃ of 0.5hPa boiling point).
Step 2 and 3:
Do not separate 3-(diisopropylaminoethyl)-4,4 under the situation of 4-difluoro fourth-3-olefin(e) acid ethyl ester (VI-1), the preparation of 4-difluoro methyl aceto acetate (I)
Figure C20048001851200141
20 ℃ with diisopropylamine (2811.6g; 27.8mol) splash into 3-[(dimethoxy phosphoryl) the oxygen base]-4,4-difluoro fourth-3-olefin(e) acid ethyl ester (VI-1) (2570g, 98.8%; 9.26mol) methyl tertiary butyl ether (18.5l) solution in, 10 minutes dropping time.(57 ℃) continue to stir 20 hours under the reflux conditions.In the time of 20 ℃ to 25 ℃, splash into the solution that the 2037g concentrated hydrochloric acid is dissolved in 4080ml water under the cooling conditions then, and continue to stir 20 hours.Two of formation is separated.Water methyl tertiary butyl ether extracting twice, each 2.3l.The organic phase that merges with the sodium chloride solution of 2.8l 10%, is used 10% sodium hydrogen carbonate solution earlier then, again with 10% sodium chloride solution washing.Use dried over sodium sulfate, filter then and reduction vaporization.Thick product is purified by distillation.
Obtain 4 of 1179g (92%, theoretical value 76.6%), 4-difluoro methyl aceto acetate.
Embodiment 2:
4-chloro-4, the preparation of 4-difluoro methyl aceto acetate (II)
Figure C20048001851200142
312.6g (3.09mol) diisopropylamine is dissolved in the tetrahydrofuran (THF) of 1.55l and is chilled to-70 ℃.In the time of-60 ℃ 852.9g (3.08mol) n-Butyl Lithium (hexane solution of 2.5mol/L) is splashed in the above-mentioned solution, 80 minutes dropping time ,-70 ℃ are continued down to stir 45 minutes.Temperature is of short duration to be in-20 ℃, is cooled to-70 ℃ more immediately.In the time of-60 ℃, splash into 264.3g (3.0mol) ethyl acetate, 50 minutes dropping time then.Splash into 242.7g chloro ethyl difluoro under the uniform temp, 30 minutes dropping time ,-65 ℃ to-70 ℃ are continued down to stir 3 hours, make temperature rise to room temperature then.Add the 4N HCl of 1500ml when rising to-5 ℃ and made reaction mixture sat 16 hours.Water phase separated (pH 6-7), organic phase is washed with the 2N HCl of 750ml and the saturated nacl aqueous solution of 1200ml.The organic phase dried over sodium sulfate is filtered and reduction vaporization.Distill thick product with further purification.
Obtain the 4-chloro-4 of 282.9g (92%, theoretical value 86.3%), 4-difluoro methyl aceto acetate.
Embodiment 3:
The preparation of chloro ethyl difluoro (VII)
Figure C20048001851200151
504.3g (3.87mol) chloro difluoroacetic acid and 5.0g tosic acid are dissolved in the 775ml methylene dichloride, and at room temperature use 311.6g (6.76mol) Ethanol Treatment 30 minutes (temperature rises to 33 ℃).Continuing under the condition that water trap exists refluxes stirred 38 hours, was chilled to room temperature then.Wash in the following order during processing: first water (200ml), use saturated sodium bicarbonate solution (200ml) then, water (200ml) is used dried over sodium sulfate again, and filtration and distillation remove desolvates.Further purify by fractionation at last.
Obtain the chloro ethyl difluoro (boiling point 94-96 ℃) of 488.9g (98%, theoretical value 78.5%).
Embodiment 4:
The preparation of 1-methyl-5-difluoromethyl-pyrazoles-4-carboxylic acid
In the time of-15 ℃ to-5 ℃ 527.8g (11.45mol) methylhydrazine being dissolved in 0.7l alcoholic acid solution splashes into 2394g (10.35mol) 2-(difluoro ethanoyl)-3-ethoxy ethyl acrylate and is dissolved in the 5.4l alcoholic acid solution; 3.5 hours dropping time, continue to stir 16 hours.Add 560g (14mol) sodium hydroxide and 3.5l water then, 50 ℃ are continued down to stir 7 hours.With reaction mixture cooling and reduction vaporization.Resistates is handled in 6l water and 7kg ice, and with washed with dichloromethane (3l, a 2l).Icy water is transferred pH to 2 with concentrated hydrochloric acid, precipitated product is leached and drying in loft drier.Under the reflux conditions thick product is dissolved in the 8l Virahol (heat), cooling was stirred 30 minutes in the time of 0 ℃ to 5 ℃, filtered, and is with 1.4l Virahol (5 ℃) washing, dry in 40 ℃ of loft drier.
Obtain 1-methyl-5-difluoromethyl pyrazole-4-carboxylic acid [Log P (pH 2.3)=0.52] of 1226.4g (99.8%, theoretical value 67.1%).
Embodiment 5:
The preparation of 3-methyl-4-difluoromethyl thiazole-5-carboxylic acid ethyl ester
28g (0.27mol) thioacetamide is added to 500ml 1,2-chloro-4 in the 2-ethylene dichloride, 4-two fluoro-ethyl 3-oxobutanoates (50.4%) and 2,2-two chloro-4, (50.4% monochloro is for compound for 68.2g, 0.2mol for the mixture of 4-two fluoro-ethyl 3-oxobutanoates, 19.2% compound of dichloro) in, reflux left standstill 16 hours in 2 hours then.Stir then and slowly add the 300ml saturated sodium bicarbonate solution down, the separation two-phase.Organic solution is with dried over sodium sulfate and reduction vaporization.Residual solution filters, with 20ml washed with dichloromethane and reduction vaporization.
Obtain 3-methyl-4-difluoromethyl thiazole-5-carboxylic acid ethyl ester [Log P (pH 2.3)=2.18] of 53.4g (72%, theoretical value 86.7%).
The mensuration of the log P value of being reported among last table and the preparation embodiment is undertaken by reversed-phase column (C18) HPLC (high performance liquid chromatography) method according to EEC the 79/831st trumpeter's volume appendix V.A8 (EEC Directive 79/831 Annex V.A8).Temperature: 43 ℃.
Phosphate aqueous solution with 0.1% is measured in the acid district of pH 2.3 (acid region), and acetonitrile is made eluent; Linear gradient from 10% acetonitrile to 90% acetonitrile.
Calibrate the log P value of described compound known (push away by in linear between two successive alkane ketone, determine log P value) based on retention time with unbranched alkane-2-ketone (3 to 16 carbon atoms).

Claims (8)

1. prepare 4 of structural formula (I), the method for 4-difluoro-acetyl-acetic acid alkylesters,
Figure C2004800185120002C1
Wherein R represents C 1-C 8Alkyl,
It is characterized in that,
The first stepIn, the 4-chloro-4 of structural formula (II), the trialkyl phosphite reaction of 4-difluoro-acetyl-acetic acid alkylesters and structural formula (III),
Figure C2004800185120002C2
Wherein R has aforesaid implication
P(OR 1) 3 (III)
Wherein
R 1Represent C 1-C 4Alkyl, and residue R 1Under any circumstance can be identical or different, the alkyl phosphonates of the structural formula that is obtained (IV) thus
Figure C2004800185120002C3
Wherein R and R 1Has aforesaid implication
Second stepIn, randomly in the presence of thinner with the reaction of the amine of structure formula V,
Figure C2004800185120002C4
Wherein
R 2And R 3Represent hydrogen or C independently of one another 1-C 8Alkyl or common representative-CH 2-CH 2-O-CH 2-CH 2-,-CH 2-CH 2-S-CH 2-CH 2-or-CH 2-CH 2-N (R 4)-CH 2-CH 2-, R 4Represent hydrogen or C 1-C 8Alkyl,
The enamine of the structural formula that is obtained (VI) thus,
Figure C2004800185120003C1
Wherein R, R 2And R 3Has aforesaid implication
The 3rd stepIn hydrolysis in the presence of acid.
2. the method for claim 1 is characterized in that, is used as the 4-chloro-4 of the structural formula (II) of starting raw material in the first step, and the 4-difluoro-acetyl-acetic acid alkylesters prepares by the following method:
The chloro difluoroacetic acid alkyl ester of structural formula (VII) in the presence of alkali and thinner with the reaction of the alkyl acetate of structural formula (VII),
Figure C2004800185120003C2
Wherein R has aforesaid implication
Figure C2004800185120003C3
Wherein R has aforesaid implication.
3. claim 1 or 2 method is characterized in that R represents C in the described structural formula of employed claim 1 (II) compound 1-C 6Alkyl.
4. claim 1 or 2 method is characterized in that
In the described structural formula of employed claim 1 (II) compound, R represent methylidene, ethyl, n-propyl, sec.-propyl, normal-butyl, isobutyl-, sec-butyl, the tertiary butyl, and
In the described structural formula of employed claim 1 (III) compound, R 1Represent methylidene, ethyl, n-propyl, sec.-propyl, normal-butyl, isobutyl-, sec-butyl, the tertiary butyl, and
In the described structure formula V of employed claim 1 compound, R 2And R 3Represent hydrogen, methyl, ethyl, n-propyl, sec.-propyl, normal-butyl, isobutyl-, sec-butyl, the tertiary butyl or common representative-CH independently of one another 2-CH 2-O-CH 2-CH 2-.
5. the method for claim 1 is characterized in that, the first step is carried out under the condition of diluent free.
6. the method for claim 1 is characterized in that the hydrolysis in the 3rd step is carried out in the presence of sulfuric acid, phosphoric acid or hydrochloric acid, each dilute with water randomly of described acid.
7. the alkyl phosphonates of structural formula (IV),
Figure C2004800185120004C1
Wherein
R represents C 1-C 8Alkyl,
R 1Represent C 1-C 4Alkyl, and residue R 1Under any circumstance can be identical or different.
8. the enamine of structural formula (VI),
Figure C2004800185120004C2
Wherein
R represents C 1-C 8Alkyl,
R 2And R 3Represent hydrogen or C independently of one another 1-C 8Alkyl or common representative-CH 2-CH 2-O-CH 2-CH 2-,-CH 2-CH 2-S-CH 2-CH 2-or-CH 2-CH 2-N (R 4)-CH 2-CH 2-, R 4Represent hydrogen or C 1-C 8Alkyl.
CNB2004800185125A 2003-07-01 2004-06-18 Method for producing difluoro-acetyl-acetic acid alkylesters Active CN100427454C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10329450 2003-07-01
DE10329450.3 2003-07-01
DE10331496.2 2003-07-11

Publications (2)

Publication Number Publication Date
CN1812959A CN1812959A (en) 2006-08-02
CN100427454C true CN100427454C (en) 2008-10-22

Family

ID=33546747

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004800185125A Active CN100427454C (en) 2003-07-01 2004-06-18 Method for producing difluoro-acetyl-acetic acid alkylesters

Country Status (4)

Country Link
JP (1) JP4727576B2 (en)
CN (1) CN100427454C (en)
AT (1) ATE519729T1 (en)
DE (1) DE10331496A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007005296A1 (en) * 2007-02-02 2008-08-07 Bayer Cropscience Ag Process for the preparation of dihaloacetacetic acid alkyl esters
US8124787B2 (en) * 2007-05-31 2012-02-28 Syngenta Crop Protection, Inc. Process for the production of pyrazoles
AU2008257515B2 (en) 2007-06-01 2014-01-23 Basf Se Method for the production of n-substituted (3-dihalomethyl-1-methyl-pyrazole-4-YL) carboxamides
EA200901652A1 (en) * 2007-06-15 2010-06-30 Басф Се Method of producing difluoromethyl-substituted pyrazole compounds
US8481778B2 (en) * 2007-08-16 2013-07-09 Solvay (Societe Anonyme) Process for the preparation of esters of 4-fluorosubstituted 3-oxo-alcanoic acids
CN106977457A (en) * 2016-12-22 2017-07-25 浙江海正化工股份有限公司 A kind of formic acid of 1 methylpyrazole of 3 difluoromethyl 4 and its synthetic method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082579B (en) * 1980-08-23 1984-02-08 Merrell Toraude & Co Fluorinated diaminobutane derivatives
NZ201468A (en) * 1981-08-10 1986-02-21 Merck & Co Inc 5-aroyl-4-pyrrolyl-alkanoic acid derivatives and pharmaceutical compositions
JPS58152831A (en) * 1982-03-08 1983-09-10 Daikin Ind Ltd Production of fluorodiketones
JP2509282B2 (en) * 1987-09-24 1996-06-19 鹿島石油株式会社 Optically active difluoro alcohol derivative
US5045554A (en) * 1988-11-29 1991-09-03 Monsanto Company Substituted thiazoles and their use as fungicides
US5093347A (en) * 1991-01-28 1992-03-03 Monsanto Company 3-difluoromethylpyrazolecarboxamide fungicides, compositions and use
US5223526A (en) * 1991-12-06 1993-06-29 Monsanto Company Pyrazole carboxanilide fungicides and use
JP2706037B2 (en) * 1993-04-13 1998-01-28 帝人株式会社 Cyano compound and method for producing the same
US5498624A (en) * 1995-05-03 1996-03-12 Monsanto Company Selected pyrazolyl derivatives
PE20011010A1 (en) * 1999-12-02 2001-10-18 Glaxo Group Ltd OXAZOLES AND THIAZOLES REPLACED AS AGONIST OF THE RECEPTOR ACTIVATED BY THE HUMAN PEROXISOMAS PROLIFERATOR

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Regiocontrolled synthesisof3-substituted-6-trifluoromethyl-4(3H)-pyrimidinones. Colin M. Tice et al.:.Tetrahedron,Vol.57 . 2001
Regiocontrolled synthesisof3-substituted-6-trifluoromethyl-4(3H)-pyrimidinones. Colin M. Tice et al.:.Tetrahedron,Vol.57 . 2001 *
Synthesis of Analogs of Farnesyl Diphosphate. Julia M. Dolence et al.:.Tetrahedron,Vol.52 No.1. 1996
Synthesis of Analogs of Farnesyl Diphosphate. Julia M. Dolence et al.:.Tetrahedron,Vol.52 No.1. 1996 *

Also Published As

Publication number Publication date
DE10331496A1 (en) 2005-01-27
CN1812959A (en) 2006-08-02
JP4727576B2 (en) 2011-07-20
ATE519729T1 (en) 2011-08-15
JP2007506673A (en) 2007-03-22

Similar Documents

Publication Publication Date Title
CN103339130B (en) Methods of making hiv attachment inhibitor prodrug compound and intermediates
CN102753531A (en) Method for producing 1-alkyl-/1-aryl-5-pyrazole-carboxylic acid derivatives
JP2007326784A (en) Method for producing 1-substituted-5-fluoroalkylpyrazole-4-carboxylic acid ester
CN103539748A (en) Method for preparing 5-(3,6-dihydro-2,6-dioxo-4-trifluoromethyl-1(2h)-pyrimidinyl)phenylthiol compounds
US7585998B2 (en) Method for producing difluoro-acetyl-acetic acid alkylesters
CN100427454C (en) Method for producing difluoro-acetyl-acetic acid alkylesters
CN102666496A (en) New preparation of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidine-5-yl)-n,n-dimethylacetamide
TWI603959B (en) Process for producing pyridazinone compound and production intermediates thereof
CN106674281B (en) A kind of Rosuvastatin midbody compound, preparation method and its usage
KR101134021B1 (en) Manufacturing method of pitavastatin hemicalcium using novel intermediates
IL206433A (en) Method for producing cyclopropanecarboxylic acid compound and intermediate therefor
AU2002340487B2 (en) Process for the preparation of 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine)
CN101824010B (en) Method for synthesizing 4-aryl-4,5-dihydrofuran
IL168110A (en) Process for production of an acetylenic compound
CN105330612B (en) The synthesis technique of 2 (base of 5 amino, 1,2,4 thiadiazoles 3) 2 methoxyimino acetic acid
JP4032861B2 (en) Process for producing β-oxonitrile derivative or alkali metal salt thereof
WO2003014067A1 (en) PROCESS FOR PRODUCING ß-OXONITRILE COMPOUND OR ALKALI METAL SALT THEREOF
EP1070692B1 (en) Methods for highly selectively o-alkylating amide compounds with the use of copper salts
KR101226332B1 (en) New preparation of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl)-N,N-dimethylacetamide
JP3855686B2 (en) 3,3-dialkoxy-2-hydroxyimino derivative and process for producing the same
WO2007086559A1 (en) Method for producing tetrahydropyran compound
JP5142241B2 (en) Method for producing nicotinic acid ester compound
CN114539125A (en) Synthetic method of pasiclovir intermediate
TW202316967A (en) Process for preparing isoxazolinecarboxylic acid derivatives
JP5071689B2 (en) 3-alkoxycarbonyl-6,7-chloromethylenedioxycoumarin compound and method for producing the same.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

Free format text: FORMER OWNER: BAYER LANDWIRTSCHAFTLICHE KULTURPFLANZEN SCIENCE AG

Effective date: 20150330

TR01 Transfer of patent right

Effective date of registration: 20150330

Address after: German Monheim

Patentee after: BAYER INTELLECTUAL PROPERTY GmbH

Address before: German Monheim

Patentee before: BAYER CROPSCIENCE AG

CP02 Change in the address of a patent holder

Address after: 50 Alfred Nobel Street, Monheim, Rhine, Germany 40789

Patentee after: BAYER INTELLECTUAL PROPERTY GmbH

Address before: Germany

Patentee before: BAYER INTELLECTUAL PROPERTY GmbH

CP02 Change in the address of a patent holder
TR01 Transfer of patent right

Effective date of registration: 20240104

Address after: 50 Alfred Nobel Street, Monheim, Rhine, Germany 40789

Patentee after: BAYER CROPSCIENCE AG

Address before: 50 Alfred Nobel Street, Monheim, Rhine, Germany 40789

Patentee before: BAYER INTELLECTUAL PROPERTY GmbH

TR01 Transfer of patent right